Q1 reports show climb in outpatient surgical volume, diverging trends at Surgery Partners, Ardent Health
Editor's Note In 2025 earnings reports for the first quarter (Q1), both Surgery Partners Inc and Ardent Health Partners Inc posted solid top-line growth and reaffirmed full-year guidance, but they diverged in outpatient performance, TipRanks May 12 reports. Surgery Partners, a major operator of ambulatory surgery centers (ASCs), reported Q1…
Tenet, HCA post strong Q1 results, but caution looms over policy uncertainty, outpatient trends
Editor's Note Tenet Healthcare and HCA Healthcare delivered robust first-quarter (Q1) earnings, bolstered by steady inpatient demand and operational discipline—but both hospital giants are treading carefully amid policy and market uncertainties, according to earnings reports covered by Healthcare Dive on April 28 and Trading View on April 29. Tenet reported…
Tenet Healthcare's strategic ASC expansion, hospital divestitures boost 2024 Q4 results
Editor's Note Tenet Healthcare closed 2024 on a high note, reporting robust fourth-quarter results driven by strategic growth in ambulatory surgery centers (ASCs) and effective cost management, Healthcare Finance February 18 and Healthcare Dive February 13 report. Partnering with United Surgical Partners International (USPI), one of the largest ASC platforms…
Free Daily News
- Study: Long working hours alter brain regions tied to emotion, cognition
- Survey: Burnout, rigid schedules push nurses to leave
- UCLA surgeons perform world’s first bladder transplant
- AHA urges HHS to cut regulations that burden hospitals and staff
- Commentary: Overlooking, underfunding perioperative mental health threatens patients
- Study: Fewer men undergo unnecessary prostate cancer surgery amid rise in active surveillance
- OpenAI benchmarking tool tests healthcare LLMs
- Healthgrades recognizes top 15% of hospitals for patient experience in 2025
- Q1 reports show climb in outpatient surgical volume, diverging trends at Surgery Partners, Ardent Health
- Study: SGLT2 inhibitors raise postop euglycemic ketoacidosis risk but lower mortality